School of Molecular Sciences, The University of Western Australia, Perth, Australia.
Mathematics and Statistics, Murdoch University, Perth, Australia.
Appl Microbiol Biotechnol. 2024 Dec;108(1):74. doi: 10.1007/s00253-023-12965-8. Epub 2024 Jan 9.
Donor human milk (DHM) provides myriad nutritional and immunological benefits for preterm and low birthweight infants. However, pasteurization leaves DHM devoid of potentially beneficial milk microbiota. In the present study, we performed milk microbiome transplantation from freshly collected mother's own milk (MOM) into pasteurized DHM. Small volumes of MOM (5%, 10%, or 30% v/v) were inoculated into pasteurized DHM and incubated at 37 °C for up to 8 h. Further, we compared microbiome recolonization in UV-C-treated and Holder-pasteurized DHM, as UV-C treatment has been shown to conserve important biochemical components of DHM that are lost during Holder pasteurization. Bacterial culture and viability-coupled metataxonomic sequencing were employed to assess the effectiveness of milk microbiome transplantation. Growth of transplanted MOM bacteria occurred rapidly in recolonized DHM samples; however, a greater level of growth was observed in Holder-pasteurized DHM compared to UV-C-treated DHM, potentially due to the conserved antimicrobial properties in UV-C-treated DHM. Viability-coupled metataxonomic analysis demonstrated similarity between recolonized DHM samples and fresh MOM samples, suggesting that the milk microbiome can be successfully transplanted into pasteurized DHM. These results highlight the potential of MOM microbiota transplantation to restore the microbial composition of UV-C-treated and Holder-pasteurized DHM and enhance the nutritional and immunological benefits of DHM for preterm and vulnerable infants. KEY POINTS: • Mother's own milk microbiome can be successfully transplanted into donor human milk. • Recolonization is equally successful in UV-C-treated and Holder-pasteurized milk. • Recolonization time should be restricted due to rapid bacterial growth.
捐赠人乳(DHM)为早产儿和低出生体重儿提供了无数的营养和免疫益处。然而,巴氏消毒会使 DHM 失去潜在有益的乳微生物群。在本研究中,我们将新鲜采集的母亲自己的奶(MOM)中的奶微生物群移植到巴氏消毒的 DHM 中。将少量 MOM(5%、10%或 30%v/v)接种到巴氏消毒的 DHM 中,并在 37°C 下孵育长达 8 小时。此外,我们比较了 UV-C 处理和 Holder 巴氏消毒的 DHM 中的微生物群再定植,因为已经证明 UV-C 处理可以保留 DHM 中在 Holder 巴氏消毒过程中丢失的重要生化成分。细菌培养和与生存力偶联的分类组学测序用于评估奶微生物群移植的效果。移植的 MOM 细菌在再定植的 DHM 样本中迅速生长;然而,在 Holder 巴氏消毒的 DHM 中观察到更高水平的生长,这可能是由于 UV-C 处理的 DHM 中保留了抗菌特性。与生存力偶联的分类组学分析表明,再定植的 DHM 样本与新鲜 MOM 样本之间存在相似性,这表明奶微生物群可以成功地移植到巴氏消毒的 DHM 中。这些结果突出了 MOM 微生物群移植的潜力,可以恢复 UV-C 处理和 Holder 巴氏消毒的 DHM 的微生物组成,并增强 DHM 对早产儿和脆弱婴儿的营养和免疫益处。关键点: • 母亲自己的奶微生物群可以成功地移植到捐赠人乳中。 • 在 UV-C 处理和 Holder 巴氏消毒的奶中再定植同样成功。 • 由于细菌生长迅速,再定植时间应受到限制。
Appl Microbiol Biotechnol. 2024-12
Front Microbiol. 2021-4-14
Front Microbiol. 2018-6-27
Breastfeed Med. 2019-2-28
Molecules. 2020-12-8
Semin Fetal Neonatal Med. 2025-7
Microbiome Res Rep. 2024-11-21
FEMS Microbiol Lett. 2023-1-17
Adv Neonatal Care. 2022-12-1
BMJ Open Gastroenterol. 2022-2
Nutrients. 2021-12-13